24 Sep 2020 13:01
24 September 2020
AIM share code: SKIN
24 September 2020
Integumen PLC
("Integumen" or "Company")
Result of Annual General Meeting
Following today's Annual General Meeting ("AGM"), convened by the Notice of AGM dated 1 September 2020, Integumen plc (to be renamed DeepVerge plc) is pleased to announce that all resolutions set out in the Notice of AGM were approved by shareholders.
The results of the poll for each resolution were as follows:
Resolution | For | % For | Against | % Against | Withheld |
1. To receive and adopt the report of the directors and the financial statements for the year ended 31 December 2019. | 24,416,932 | 99.88% | 4,444 | 0.02% | 25,000 |
2. To re-appoint Jeffreys Henry LLP as auditors. | 24,416,932 | 99.88% | 4,444 | 0.02% | 25,000 |
3. To determine the remuneration of the auditors. | 24,416,932 | 99.88% | 4,444 | 0.02% | 25,000 |
4. To re-elect Ross Andrews as a director of the Company. | 23,082,691 | 94.42% | 1,338,685 | 5.48% | 25,000 |
5. To authorise the directors to allot shares pursuant to Section 551 of the Companies Act 2006. | 24,393,803 | 99.78% | 27,574 | 0.11% | 25,000 |
6. To authorise the directors to allot shares for cash pursuant to Section 571(1) of the Companies Act 2006. | 24,379,570 | 99.73% | 66,806 | 0.27% | - |
As at the date of the AGM, the number of issued ordinary shares of the Company was 113,185,643 shares, which was the total number of shares entitling the holders to attend and vote for or against all resolutions. In accordance with the Company's Articles of Association, on a poll every member has one vote for every share held. Votes withheld are not votes in law and have not been counted in the calculation of the proportion of vote "for" or "against" a resolution. Proxy appointments which gave discretion to the Chairman have been included in the "for" total.
Following today's AGM result, a short video will be posted on the Company's website: https://www.integumen.com/investors/
For further information please visit http://www.integumen.com/ or contact:
Enquiries:
Integumen plc | Gerard Brandon, CEO | +44 (0) 7340 055 648 |
SPARK Advisory Partners Limited (Nominated Adviser) | Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker | +44 (0) 20 3621 4120 |
About Integumen
Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.